Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease.

Kai J RogersMouaz AlsawasJames ChapmanAnnette J SchlueterCharles Michael Knudson

Published in: Transfusion (2024)

The RoR in HbS is a relatively consistent parameter for individual patients that is unaffected by medication use or procedural Hct targets and may be useful in determining intervals between procedures.

Keyphrases

sickle cell disease
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
red blood cell
patient reported outcomes